AVL-3288
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AVL-3288, covering 2019-01-22 to 2024-11-06. Get the full timeline:
Most recent: Clinical Trial Update: The Use of AVL-3288 to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine [Phase 1]